Conference Information

Welcome Message

CLINICAL TRIALS 2021 welcomes you all!!

We take a great pride to our highly reputed global event welcoming all the attendees for our “3rd International Virtual Conference on Clinical Trials and Case Reports” during November 24-25, 2021 in webinar session. This conference will deliver new ideas, convictions, strategies and tactics where no conference will offer an impressive roaster of Keynote speakers, quality attendees, and compelling content. The various thematic sessions will be discussed at this conference; we welcome all of you to attend the conference.

This is an excellent opportunity for the delegates from fields of healthcare to interact with the world class Scientists. The interested participants can confirm their participation by registering for the CLINICAL TRIALS 2021 along with your colleagues. This Conference will provide an excellent platform for the exchange of ideas on authoritative views by leading scientists in clinical trials in healthcare as well as business leaders and investors in this exciting field.

Once again, we feel satisfied to have all your quality and your creative research works. The calculated and relevant learning shared, will likewise cultivate authoritative coordinated efforts to sustain logical scientific accelerations. We guarantee you would have an incredible involvement with and affection to the wonderful webinar session.

Meet and Explore !!

Regards
Organizing committee
Clinical trials 2021

About Conference

We are looking forward to welcoming you to the “3rd International Virtual Conference on Clinical Trials and Case Reports” were held in webinar session from November 24-25, 2021.

It is the one among the best platform to have the discussion innovative researches and developments in the field of cluster of clinical trials.

International Conference on Clinical Trials and Case Reports is intended to urge more noteworthy collaboration to offer a forum that will connect people worldwide for the exchange of ideas under the theme “Emerging trends in Clinical trialsand case report”.

Clinical trials 2021 is a global event focusing on the immense knowledge and major advances in the rapidly emerging fields of drug discovery by attracting experts and professionals across the universe.

Why to attend?

With the huge number of participants across the globe, focussed on Clinical Trials 2021 learning about the recent trends in clinical trials and its major impacts. Clinical trials 2021 are research studies performed in folks that are aimed toward evaluating a medical, surgical, or behavioural intervention. They’re the first way that researchers determine if a replacement treatment, sort of a new drug or diet or medical device This 2-day program will offer the best opportunity to conduct oral talks and others.

Who attends?

Clinical Trials 2021 experts in the field Personalized medicine experts & Healthcare departments. Professional investigator who is usually a medical doctor. Clinical studies even have a search team which will include doctors, nurses, social workers, and other health care professionals. And also for the students who are all interested in research in clinical studies.

The conference highlights:

Clinical operations & design
Clinical research and trials on cancer
Pharmaceutical sciences
Patient Centric clinical trials
Clinical trials in different diseases
Clinical data management
Innovations in clinical trials
Drug development and metabolism
Clinical case report
Future clinical trials

Benefits of Attending Webinar

Gain Certified for your participation.
Improved research and innovation ideas are easily accessible.
Access to the world's most prestigious pharmaceutical, biotechnology, industrial, and biochemical firms.
Connect with industry leaders such as huge companies, hospitals, laboratories, universities, government agencies, investors, and entrepreneurs.
Gain recognition for your participation.
Affordability and reduced costs.
Take down Geographical Barriers.
Convenience from the comfort of your own home or from your place of business
They have been archived: Viewing of Events in the Recording.
Excellent resource for gaining new job skills.
Take Advice from the Experts.
Global Awareness of Your Research.
Make new relationships.
Increased involvement.
More interesting.
Place yourself as the expert.

Target audience

CEOs/COOs/Director
Vice President
Co-directors
Faculty, Students, and Scientists in Biotechnology
Faculty, students and scientists in Biomedical Engineering
Faculty, Students and Scientists in bioscience
Young scientists and researchers
Associations and Societies in Biotechnology
Biotechnologists
Business Professionals
Bioengineers
Industrial Experts
Medical Colleges and Hospitals
Consumer Product Dealers/Managers

Call for Submissions:

We are currently accepting abstracts from relevant researchers/experienced professionals to share their knowledge in the field. For any clarification on the program, please contact the program manager via email.

Sessions and Tracks

TRACK 1: Clinical operations & design

Clinical study design is that the formulation of trials and experiments, also as observational studies in medical, clinical and other kinds of research involving citizenry. Clinical trials are typically conducted in four phases, each phase is taken into account as separate trial and, after completion of a phase, and investigators are required to submit their data for approval from the FDA before continuing to subsequent phase. sorts of study designs are Meta-Analysis, Systematic Review, Randomized Controlled Trial, Cohort Study, Comparative Study, Case-control Study, Cross-sectional study, Case Reports and Series, Animal Research Studies, Test-tube Lab Research.

RELATED ASSOCIATIONS:

Association of clinical research organization (ACRO) | Association of clinical research professionals (ACRP) | Association of the British Pharmaceutical Industry (ABPI) | American College of Clinical Pharmacology (ACCP) | American Society for Clinical Pharmacology and Therapeutics (ASCPT) | British Association of Research Quality Assurance (BARQA) | Clinical Contract Research Association (CCRA) | Consortium of Independent Review Boards (CIRB) | The Institute of Clinical Research (ICR)

TRACK 2: Clinical research and trials on cancer

In cancer several treatments, screening, palliative care and prevention trials are taken place. It is used to get answers for the various queries from researchers to get a idea and help in future. Clinical trials for cancer are research studies that compare the foremost effective known treatment for a selected type or stage of cancer with a replacement approach. This will be a replacement drug, or combination of medicine or a special way of using established therapies.

RELATED ASSOCIATIONS:

TRACK 3: Pharmaceutical sciences

With the rising number of patients affected by differing types of cancer, favorable reimbursement scenario in US, improved and advanced healthcare infrastructure have driven North America to become the leading regional segment within the global NDDS in cancer therapy market. Among the NDDS technologies Embolization of Particles, Selective Internal radiotherapy (SIRT), Holmium-based Microspheres, carrier protein, Liquid Embolic and Nanoparticles are gaining importance from market point of view.

RELATED ASSOCIATIONS:

TRACK 4: Patient Centric clinical trials

According to generally recognized standards, patient engagement should extend far beyond consideration as study participants. Patients have an important role in all phases of trial design and implementation. Patient-centric medication development also provides a significant opportunity to define relevant outcomes from the patient's point of view, as a means of ensuring that the needs and goals of patient groups are reflected.

RELATED ASSOCIATIONS:

TRACK 5: Clinical trials in different diseases

Clinical trials for various diseases and disorders help to evaluate one or more interventions for treating a disease, syndrome, or condition, as well as to find ways to prevent the onset or recurrence of a disease, syndrome, or condition. Medicines, vaccinations, and lifestyle modifications are examples of such interventions.

RELATED ASSOCIATIONS:

TRACK 6: Clinical data management

The process in clinical data management is to gather, clean, integrated and manage the topic of knowledge in compliance with regulatory standards. it is a process were introduce critical clinical research, which ends up within the generation of high-quality, reliable, and statistically sound data from clinical trials, this has been facilitated. It can support the conduct, management, and analysis of studies across the spectrum of clinical research.

RELATED ASSOCIATIONS:

TRACK 7: Innovations in clinical trials

Now a day, the utilization of Adaptive design methods in clinical research has become increasingly popular thanks to its flexibility and efficiency. Adaptive designs offer the potential to scale back study duration and patient exposure whilst maximizing the probability of a successful outcome. Another innovation in clinical trials is that the Bucket design. Bucket trials are designed to utilize one particular drug and test that drug delivery against a variety of various diseases. The advantage of this approach is that patients with different diseases are often 'pooled' together under one larger trial rather than many smaller trials, thereby saving time and resources during a similar approach, and there are more innovations in clinical trials.

RELATED ASSOCIATIONS:

TRACK 8: Drug development and metabolism

The drug discovery process involves identifying an appropriate target that's a molecule or a protein receptor that's specifically related to a disease condition or pathology. Once a target is identified, the subsequent step involves understanding how the target plays a task within the disease process of precision medicine. This is often followed by testing of the target against different known and new compounds to spot either one or several ‘lead compounds’ which interact with the target.

RELATED ASSOCIATIONS:

TRACK 9: Clinical case report

Clinical case reports are used to get the results of the condition or status of the medical report for the applied clinical immunology trials for diagnosis, treatment, signs, and condition of the patients. This clinical case report is used to prevent the patient from the critical condition. These case reports can act as the demographic status of the patients. And this clinical trial is an emerging function in the medical field.

RELATED ASSOCIATIONS:

TRACK 10: Future trends on clinical trials

The future of clinical trials illustrated as follows. Access and have interaction the patient online – Attract patients to the trial – Consent patients & convert to subjects – Remotely manage subjects & collect data. The sponsor plans to interact the patient through social media, like Facebook, and regular e-mail updates so as to draw in the patient to the trial, and once the patient agrees to find out more about the trial, the sponsor mails the patient a package containing mobile health devices, which collect medical diagnostic data and sends that clinical data to the sponsor. The patient activates the tablet, which contains an electronic consent and a video of a physician explaining the clinical test intimately. Humanization in digital media is believed to be an efficient tool that's wont to communicate with patients. During the clinical test, the topic is in a position to access live physicians either virtually or through nearby medical profession centers.

RELATED ASSOCIATIONS:

Market Analysis

Clinical trials 2021 are research studies performed in folks that are aimed toward evaluating a medical, surgical, or behavioural intervention. They’re the first way that researchers determine if a replacement treatment, sort of a new drug or diet or medical device (for example, a pacemaker) is safe and effective in people.

The clinical trials market was worth roughly USD 38,213.3 million in 2020, and it is anticipated to grow to USD 51,356 million by 2026, with a CAGR of 5.05 percent from 2021 to 2026.The high need for clinical trials in growing economies, the pharmaceutical industry's high R&D investment, and a rising prevalence of clinical trials are all significant drivers driving the market's expansion.

IMPORTANCE:

The COVID-19 pandemic has had a significant impact on the clinical trial market, as the development of novel treatments or vaccinations to prevent or treat the disease has become a top priority. Furthermore, COVID-19 has resulted in a minor change in the way clinical trials are conducted. Virtual trials have been featured on conference agendas and in magazine articles for a long time in the clinical trial area, and they have been featured on conference agendas and in magazine articles. Despite this, most businesses continue to use the same procedures. COVID-19, on the other hand, has practically compelled some of the trials to switch to a virtual model in order to keep them on schedule during this pandemic.

Aging is also proven to be a major driver of illness burden and demand in the market analysed. With the increased prevalence of diseases, market participants are increasingly focusing on creating new treatments for uncommon or genetic disorders that require expertise and targeted clinical trials, which is projected to drive market expansion.

Chronic disease is becoming more prevalent, according to the World Health Organization (WHO). This is projected to enhance demand for novel drug development as well as clinical trials. It has been discovered that cardiovascular illnesses, obesity, and diabetes account for about half of all chronic disease deaths, and that these diseases are on the rise.

SCOPE OF REPORT:

Clinical trials, according to the report's definition, are tests that are carried out under the auspices of clinical research and adhere to a strict procedure. These tests are generally used to gather information about the safety and efficacy of newly discovered medicines. These trials are divided into three phases (I, II, and III), each of which is dependent on different circumstances. This procedure is not only costly, but also time-consuming, and it needs professional knowledge at every level.
In By phase (phase 1, phase 2, phase 3, phase 4), by design in treatment studies (Randomized Control Trial, Adaptive Clinical Trial, Non-randomized Control Trial) & observational studies (Cohort Study, Case Control Study, Cross Sectional Study, Ecological Study) and by geography(North America, Europe, Asia –pacific, South America).

KEY MARKET TRENDS:

Phase III is projected to dominate the industry, with Phase I expected to expand at the quickest rate. Phase III is one of the most important stages in determining whether or not a novel intervention is effective and useful in clinical practice.

These Phase III clinical studies are used to compare the effects of a new medicine to those of previously existing medications, or to validate and expand on the safety and efficacy findings of Phase I and II trials. Due to their increasing complexity and requirement for outsourcing services, these clinical trials continue to have a larger demand for outsourcing services than Phase II and Phase I studies.

Because of the presence of large outsourcing businesses and increased R&D in the area, North America has dominated the entire industry. This is mostly owing to factors such as rising R&D expenditures and rising demand for medication development, which are the primary drivers of the market's rise in the United States.

There also are favourable government initiatives regarding clinical trials within the US that are anticipated to spice up the market growth. As an example, in March 2020, the FDA launched a Coronavirus Treatment Acceleration Program (CTAP) for possible therapies to hurry up the event of treatment for the worldwide disease caused by the coronavirus.

In the US, pharmaceutical companies are found spending extra money time, and energy on R&D than most organizations. Consistent with the National Institute of Health data, within the financial year 2017, clinical research funding by the NIH was around USD 12.7 billion, and it increased to USD 15 billion in 2019. Moreover, with the increasing of diseases, the amount of clinical trials is predicted to rise within the coming few years.

INTENDED AUDIENCE:

Professional investigator who is usually a medical doctor. Clinical studies even have a search team which will include doctors, nurses, social workers, and other health care professionals. And also for the students who are all interested in research in clinical studies.

TOP ASSSOCIATION FOR CLINICAL TRAILS:

Association of clinical research organization (ACRO), Association of clinical research professionals (ACRP), Association of the British Pharmaceutical Industry (ABPI), American College of Clinical Pharmacology (ACCP), American Society for Clinical Pharmacology and Therapeutics (ASCPT), British Association of Research Quality Assurance (BARQA), Clinical Contract Research Association (CCRA), Consortium of Independent Review Boards (CIRB), The Institute of Clinical Research (ICR).

3rd International Virtual Conference on
Clinical Trials and Case Reports

Quick Links

Theme: Exploring the emerging trends in clinical trials and case report

Conference Information

Welcome Message

CLINICAL TRIALS 2021 welcomes you all!!

About Conference

Sessions and Tracks

Market Analysis